Are you Dr. Schlesinger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 47 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
456 W 10th Ave
Columbus, OH 43210Phone+1 614-947-3700Fax+1 614-947-3771- Is this information wrong?
Summary
- Dr. Larry Schlesinger, MD is an infectious disease specialist in Columbus, Ohio. He is currently licensed to practice medicine in Ohio. He is a Professor at Ohio State University College of Medicine.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1986 - 1989
- University of Michigan Health SystemResidency, Internal Medicine, 1982 - 1986
- Rutgers Robert Wood Johnson Medical SchoolClass of 1982
Certifications & Licensure
- OH State Medical License Active through 2014
Publications & Presentations
PubMed
- 2 citationsCy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis.Ramiro E. Toribio, Nicholas A. Young, Larry S. Schlesinger, Fred Cope, David Ralph, Wael N. Jarjour, Thomas J. Rosol> ;Journal of Orthopaedic Research. 2021 Apr 1
- 19 citationsCurrent Sarcoidosis Models and the Importance of Focusing on the Granuloma.Landon W. Locke, Larry S. Schlesinger, Elliott D. Crouser> ;Frontiers in Immunology. 2020 Aug 4
- 40 citationsIFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infectionBruce A. Rosa, Mushtaq Ahmed, Dhiraj Kumar Singh, José Alberto Choreño-Parra, Journey Cole, Luis Jiménez-Alvarez, Tatiana S. Rodriguez-Reyna, Bindu Singh, Olga Gonzale...> ;Biorxiv. 2020 Aug 6
- Join now to see all
Press Mentions
- San Antonio’s South, West Sides to Get More Medical Facilities, New Public Health SchoolJune 10th, 2022
- COVID-19 Vaccine Mandate by Texas Biomed Will Protect Not Just HumansAugust 19th, 2021
- Major SA Biotech Campus Requires Covid Vaccinations for All EmployeesAugust 16th, 2021
- Join now to see all
Grant Support
- Host Bacterial Targets Mediating Immune Suppression In Pneumonic TularemiaNational Institute Of Allergy And Infectious Diseases2009–2012
- Medical Scientist Training Program - Ohio State UniversityNational Institute Of General Medical Sciences2011
- Interdisciplinary Study Of The Microbe-Host InterfaceNational Institute Of Allergy And Infectious Diseases2007–2011
- Acquisition Of A MALDI-TOF/TOF MS For Glycomic And Lipidomic ResearchNational Center For Research Resources2010
- Altered M. Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2006–2010
- TB And Innate Immune Regulation Of Lung MacrophagesNational Institute Of Allergy And Infectious Diseases2005–2009
- Lung Innate Immure Responses To F. Tularensis: A Central Role For The MacrophageNational Institute Of Allergy And Infectious Diseases2008
- Mycobacterium Tuberculosis Lipoarabinomannan Metabolism Within Human MacrophagesNational Institute Of Allergy And Infectious Diseases2007–2008
- Altered Mycobacterium Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2007
- TB And Innate Immune Regulation Of Lung MacrophagesNational Institute Of Allergy And Infectious Diseases2004
- Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases2002
- Altered M. Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2002
- Surfactant Proteins In Pathogenesis Of TuberculosisNational Center For Research Resources2000–2002
- Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases1998–2002
- Gallium Therapy For Mycobacterial InfectionsNational Institute Of Allergy And Infectious Diseases1998–1999
- Surfactant Proteins In The Pathogenesis Of TuberculosisNational Center For Research Resources1997
- Surfactant Proteins In The Pathogenesis Of TuberculosisNational Heart, Lung, And Blood Institute1993–1997
- Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases1992–1996
- Human Monocyte Interactions W/Mycobacterium LepraeNational Institute Of Allergy And Infectious Diseases1988–1991